Steminent Biotherapeutics Inc. (TPEX:7729)
Taiwan · Delayed Price · Currency is TWD 188.50
-2.50 (-1.31%)
Nov 6, 2026, 1:59 PM CST
Steminent Biotherapeutics Market Cap
Steminent Biotherapeutics has a market cap or net worth of 15.19 billion as of November 6, 2026. It is the 14,783rd most valuable company in the world and the 479th biggest in Taiwan. Its market cap has increased by 574.34% in one year.
Market Cap
15.19B
Enterprise Value
14.37B
Revenue
n/a
Global Rank
Country Rank
#479 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since March 11, 2024, Steminent Biotherapeutics's market cap has increased from 2.24B to 15.19B, an increase of 578.03%. That is a compound annual growth rate of 105.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 15.11B | 277.27% |
| Dec 31, 2025 | 4.00B | 211.83% |
| Dec 31, 2024 | 1.28B | -42.67% |
| Mar 11, 2024 | 2.24B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 21.55B |
| Sunmax Biotechnology | 21.27B |
| CHO Pharma | 16.11B |
| Medigen Vaccine Biologics | 15.42B |
| TaiMed Biologics | 15.03B |
| Ever Supreme Bio Technology | 14.56B |
| EirGenix | 14.01B |
| Gongwin Biopharm Holdings | 12.17B |